{
    "2021-04-01": [
        [
            {
                "time": "",
                "original_text": "社保QFII最新调仓！两类资金分歧巨大",
                "features": {
                    "keywords": [
                        "社保",
                        "QFII",
                        "调仓",
                        "资金分歧"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药股开启反弹，机构：把握大幅回调的核心资产布局机会",
                "features": {
                    "keywords": [
                        "医药股",
                        "反弹",
                        "机构",
                        "核心资产",
                        "布局机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券---华兰生物：业绩符合预期，流感疫苗大幅增长【公司研究】",
                "features": {
                    "keywords": [
                        "西南证券",
                        "华兰生物",
                        "业绩",
                        "流感疫苗",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物(002007)：流感疫苗高增长 业绩符合预期",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "流感疫苗",
                        "高增长",
                        "业绩"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "养老金去年末现身40只股前十大流通股东榜",
                "features": {
                    "keywords": [
                        "养老金",
                        "现身",
                        "流通股东榜"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "平安证券---生物医药行业动态跟踪报告：2021一季度业绩前瞻，行业整体表现优异，核心板块快速增长【行业研究】",
                "features": {
                    "keywords": [
                        "平安证券",
                        "生物医药",
                        "业绩前瞻",
                        "核心板块",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "深夜重磅！深交所两板合并倒计时，23万亿大板块启航！再见，中小板！",
                "features": {
                    "keywords": [
                        "深交所",
                        "两板合并",
                        "倒计时",
                        "中小板"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}